Atlas Trials

Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies

Clinical trial NCT05443425 · RECRUITING

Trial details

NCT number
NCT05443425
Sponsor
City of Hope Medical Center
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Graft Versus Host DiseaseHematopoietic and Lymphoid System Neoplasm
Start date
2023-06-16
Primary completion
2027-01-05
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.